DRAGARWQ Q1 FY27 results at a glance
DR. AGARWAL'S EYE HOSP L Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹143 cr |
|---|
| Revenue YoY | +22.3% |
|---|
| Operating profit | ₹31.77 cr |
|---|
| Operating margin | 22.2% |
|---|
| Net profit | ₹23.38 cr |
|---|
| Net profit YoY | +35.5% |
|---|
| Net profit QoQ | +44.0% |
|---|
| Net margin | 16.4% |
|---|
| Basic EPS | ₹48.38 |
|---|
| TTM revenue | ₹496 cr |
|---|
| TTM net profit | ₹74.16 cr |
|---|
| TTM net margin | 14.9% |
|---|
DRAGARWQ Q1 FY27 results: what the numbers say
DR. AGARWAL'S EYE HOSP L (DRAGARWQ) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹143 cr and a net profit of ₹23.38 cr, translating into earnings per share of ₹48.38.
Compared with the same quarter a year earlier, revenue grew strongly by +22.3% and net profit grew strongly by +35.5%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹31.77 cr, an operating margin of 22.2% versus 22.7% a year ago — a contraction of 0.5 percentage points.
DRAGARWQ quarter-wise results table
Net profit
₹23.38 cr
+35.5% YoY
Operating profit
₹31.77 cr
+19.7% YoY
DR. AGARWAL'S EYE HOSP L (DRAGARWQ) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹143 cr | ₹31.77 cr | ₹23.38 cr | 22.2% | 16.4% | ₹48.38 | +35.5% | +44.0% |
| Q4 FY262026-03-31 | ₹120 cr | ₹21.64 cr | ₹16.24 cr | 18.0% | 13.5% | ₹33.60 | +1.6% | -6.0% |
| Q3 FY262025-12-31 | ₹116 cr | ₹22.71 cr | ₹17.28 cr | 19.5% | 14.9% | ₹35.76 | — | +0.1% |
| Q1 FY262025-06-30 | ₹117 cr | ₹26.55 cr | ₹17.26 cr | 22.7% | 14.8% | ₹36.72 | — | +7.9% |
| Q4 FY252025-03-31 | ₹99.83 cr | ₹21.39 cr | ₹15.99 cr | 21.4% | 16.0% | — | — | — |
| TTM (last 4 quarters) | ₹496 cr | ₹103 cr | ₹74.16 cr | 20.7% | 14.9% | ₹154.46 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
DRAGARWQ quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
DR. AGARWAL'S EYE HOSP L quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q1 FY262025-06-30 | Q4 FY252025-03-31 |
|---|
| Revenue / Sales | ₹143 cr | ₹120 cr | ₹116 cr | ₹117 cr | ₹99.83 cr |
|---|
| Total expenses | ₹111 cr | ₹98.37 cr | ₹93.51 cr | ₹90.37 cr | ₹78.44 cr |
|---|
| Gross profit | ₹113 cr | ₹95.04 cr | ₹90.76 cr | ₹90.78 cr | ₹78.22 cr |
|---|
| Operating profit (EBIT) | ₹31.77 cr | ₹21.64 cr | ₹22.71 cr | ₹26.55 cr | ₹21.39 cr |
|---|
| Operating margin | 22.2% | 18.0% | 19.5% | 22.7% | 21.4% |
|---|
| Interest cost | ₹2.77 cr | ₹1.96 cr | ₹2.03 cr | ₹4.16 cr | ₹2.89 cr |
|---|
| Profit before tax | ₹30.96 cr | ₹21.26 cr | ₹23.45 cr | ₹23.19 cr | ₹18 cr |
|---|
| Tax expense | ₹7.58 cr | ₹5.01 cr | ₹6.17 cr | ₹5.93 cr | ₹2.61 cr |
|---|
| Effective tax rate | 24.5% | 23.6% | 26.3% | 25.6% | 14.5% |
|---|
| Net profit (PAT) | ₹23.38 cr | ₹16.24 cr | ₹17.28 cr | ₹17.26 cr | ₹15.99 cr |
|---|
| Net profit margin | 16.4% | 13.5% | 14.9% | 14.8% | 16.0% |
|---|
| Basic EPS | ₹48.38 | ₹33.60 | ₹35.76 | ₹36.72 | — |
|---|
| Diluted EPS | ₹48.38 | ₹33.60 | ₹35.76 | ₹36.72 | — |
|---|
DRAGARWQ results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q1 FY26 | Q4 FY25 |
|---|
| Revenue YoY | +22.3% | +20.2% | — | — | — |
|---|
| Revenue QoQ | +19.1% | +3.3% | -0.6% | +17.1% | — |
|---|
| Operating profit YoY | +19.7% | +1.2% | — | — | — |
|---|
| Operating profit QoQ | +46.8% | -4.7% | -14.5% | +24.1% | — |
|---|
| Net profit YoY | +35.5% | +1.6% | — | — | — |
|---|
| Net profit QoQ | +44.0% | -6.0% | +0.1% | +7.9% | — |
|---|
| EPS YoY | +31.8% | — | — | — | — |
|---|
| EPS QoQ | +44.0% | -6.0% | -2.6% | — | — |
|---|
DRAGARWQ annual results history
Full-year performance for DR. AGARWAL'S EYE HOSP L, useful for reading each quarter in context.
DR. AGARWAL'S EYE HOSP L annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹470 cr | ₹394 cr | ₹317 cr | ₹267 cr |
|---|
| Total expenses | ₹368 cr | ₹313 cr | ₹251 cr | ₹210 cr |
|---|
| Gross profit | ₹368 cr | ₹304 cr | ₹246 cr | ₹206 cr |
|---|
| Operating profit (EBIT) | ₹102 cr | ₹81.33 cr | ₹66.02 cr | ₹56.47 cr |
|---|
| Operating margin | 21.7% | 20.6% | 20.9% | 21.2% |
|---|
| Interest cost | ₹11.83 cr | ₹12.36 cr | ₹7.1 cr | ₹6.8 cr |
|---|
| Profit before tax | ₹93.61 cr | ₹70.7 cr | ₹62.25 cr | ₹49.4 cr |
|---|
| Tax expense | ₹23.51 cr | ₹16.05 cr | ₹15.89 cr | ₹12.48 cr |
|---|
| Effective tax rate | 25.1% | 22.7% | 25.5% | 25.3% |
|---|
| Net profit (PAT) | ₹70.1 cr | ₹54.65 cr | ₹46.36 cr | ₹36.92 cr |
|---|
| Net profit margin | 14.9% | 13.9% | 14.6% | 13.8% |
|---|
| Basic EPS | ₹147.02 | ₹116.28 | ₹98.64 | ₹78.55 |
|---|
| Diluted EPS | ₹147.02 | ₹116.28 | ₹98.64 | ₹78.55 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹143 cr against ₹117 cr in Q1 FY26, and ₹120 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +19.1%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹111 cr, or 77.8% of revenue, with operating profit grew +19.7% year on year.
Margins, tax and profitability
Net profit of ₹23.38 cr works out to a net margin of 16.4% compared with 14.8% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, DR. AGARWAL'S EYE HOSP L reported profit before tax of ₹30.96 cr, a tax charge of ₹7.58 cr (effective rate 24.5%), interest cost of ₹2.77 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹16.24 cr in Q4 FY26 to ₹23.38 cr in Q1 FY27, a change of +44.0%.
Trailing twelve months and annual context
Across the trailing four quarters DR. AGARWAL'S EYE HOSP L has generated revenue of ₹496 cr and net profit of ₹74.16 cr, a trailing net margin of 14.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹470 cr with net profit of ₹70.1 cr and EPS of ₹147.02, versus the prior year where revenue grew +19.2% and profit grew +28.3%.
What to watch in the next DRAGARWQ quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
DR. AGARWAL'S EYE HOSP L has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
DRAGARWQ results coverage
No results report published for DRAGARWQ yet — our desk covers each quarter within minutes of the filing.
DRAGARWQ quarterly results FAQs
What were DR. AGARWAL'S EYE HOSP L (DRAGARWQ) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), DR. AGARWAL'S EYE HOSP L reported revenue of ₹143 cr and net profit of ₹23.38 cr, a change of +35.5% year on year on +22.3% revenue growth. EPS stood at ₹48.38.
What is DRAGARWQ profit margin in Q1 FY27?
DR. AGARWAL'S EYE HOSP L posted a net profit margin of 16.4% and an operating margin of 22.2% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹496 cr and net profit ₹74.16 cr.
Did DRAGARWQ results beat the previous quarter?
DR. AGARWAL'S EYE HOSP L net profit changed +44.0% quarter on quarter, from ₹16.24 cr in Q4 FY26 to ₹23.38 cr in Q1 FY27.
When are DR. AGARWAL'S EYE HOSP L (DRAGARWQ) quarterly results?
DR. AGARWAL'S EYE HOSP L has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see DRAGARWQ latest quarterly results?
Results coverage for DRAGARWQ will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the DRAGARWQ stock page.
What is DR. AGARWAL'S EYE HOSP L annual revenue and profit?
For FY26, DR. AGARWAL'S EYE HOSP L reported full-year revenue of ₹470 cr and net profit of ₹70.1 cr, with EPS of ₹147.02.
How many quarterly results has DRAGARWQ declared recently?
Past results dates for DRAGARWQ will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
